Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus in intensive care units

Comment

H Humphreys et al. J Hosp Infect. 2005 Mar.

. 2005 Mar;59(3):259-61; author reply 263-6.

doi: 10.1016/j.jhin.2004.08.002.

No abstract available

Comment in

Controlling MRSA: what is the way forward?
Barrett SP, Simmons NA. Barrett SP, et al. J Hosp Infect. 2005 Mar;59(3):170-1. doi: 10.1016/j.jhin.2004.12.002. J Hosp Infect. 2005. PMID: 15694972 No abstract available.

Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit.
de la Cal MA, Cerdá E, van Saene HK, García-Hierro P, Negro E, Parra ML, Arias S, Ballesteros D. de la Cal MA, et al. J Hosp Infect. 2004 Mar;56(3):175-83. doi: 10.1016/j.jhin.2003.09.021. J Hosp Infect. 2004. PMID: 15003664
MRSA--time for a more pragmatic approach?
van Saene HK, Weir WI, de la Cal MA, Silvestri L, Petros AJ, Barrett SP. van Saene HK, et al. J Hosp Infect. 2004 Mar;56(3):170-4. doi: 10.1016/j.jhin.2004.01.018. J Hosp Infect. 2004. PMID: 15055209 Review. No abstract available.